Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of a National Radiation Oncology Research and Mentorship Program.
Jin R, Wu CHD, Giuliani M, Doll C, Ringash J, Lavigne D, Ingledew PA. Jin R, et al. Among authors: doll c. Int J Radiat Oncol Biol Phys. 2024 Apr 4:S0360-3016(24)00465-6. doi: 10.1016/j.ijrobp.2024.03.040. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 38582234
Impact of the COVID-19 Pandemic on Canadian Radiation Oncology Practices.
Doll CM, Wakefield DV, Ringash J, Ingledew PA, Dawson LA, Eichler T, Schwartz DL. Doll CM, et al. Int J Radiat Oncol Biol Phys. 2022 Jul 1;113(3):513-517. doi: 10.1016/j.ijrobp.2022.03.017. Epub 2022 Mar 19. Int J Radiat Oncol Biol Phys. 2022. PMID: 35318953 Free PMC article.
Long-Term Patient-Reported Quality of Life of Anal Cancer Survivors Treated With Intensity Modulated Radiation Therapy and Concurrent Chemotherapy: Results From a Prospective Phase II Trial.
Joseph K, Balushi MA, Ghosh S, Stenson T, Abraham A, Elangovan A, Warkentin H, Paulson K, Tankel K, Usmani N, Severin D, Schiller D, Wong C, Mulder K, Doll C, King K, Nijjar T. Joseph K, et al. Among authors: doll c. Int J Radiat Oncol Biol Phys. 2023 Oct 1;117(2):434-445. doi: 10.1016/j.ijrobp.2023.04.023. Epub 2023 May 4. Int J Radiat Oncol Biol Phys. 2023. PMID: 37148982 Clinical Trial.
A prospective phase I-II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment.
Herrera FG, Chan P, Doll C, Milosevic M, Oza A, Syed A, Pintilie M, Levin W, Manchul L, Fyles A. Herrera FG, et al. Among authors: doll c. Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):97-103. doi: 10.1016/j.ijrobp.2006.08.024. Epub 2006 Oct 23. Int J Radiat Oncol Biol Phys. 2007. PMID: 17056201 Clinical Trial.
The significance of tumoral ERCC1 status in patients with locally advanced cervical cancer treated with chemoradiation therapy: a multicenter clinicopathologic analysis.
Doll CM, Aquino-Parsons C, Pintilie M, Klimowicz AC, Petrillo SK, Milosevic M, Craighead PS, Clarke B, Lees-Miller SP, Fyles AW, Magliocco AM. Doll CM, et al. Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):721-7. doi: 10.1016/j.ijrobp.2012.06.021. Epub 2012 Jul 24. Int J Radiat Oncol Biol Phys. 2013. PMID: 22836058
190 results